NeoGenomics, Inc. (NEO) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$9.77M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$18.24M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$27.01M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$47.63M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$9.77M | (m) | (m) | (m) | $8.22M* | $19.96M* | $109.78M | $10.76M | (m) | -$412.00K |
| 2026-03-31 | Reported | (m) | -$18.24M | (m) | (m) | (m) | $5.00M | -$8.14M | $105.81M | $9.53M | (m) | -$472.00K |
| 2025-09-30 | Reported | (m) | -$27.01M | (m) | (m) | (m) | $8.31M* | $8.88M* | $107.35M | $8.69M | (m) | $740.00K |
| 2025-06-30 | Reported | (m) | -$47.63M | (m) | (m) | (m) | $6.32M* | $20.33M* | $104.07M | $9.02M | (m) | -$724.00K |
| 2025-03-31 | Reported | (m) | -$27.82M | (m) | (m) | (m) | $4.50M | -$25.33M | $94.79M | $10.18M | (m) | $266.00K |
| 2024-09-30 | Reported | (m) | -$21.20M | (m) | (m) | (m) | $10.80M* | $9.25M* | $92.94M | $7.68M | (m) | -$150.00K |
| 2024-06-30 | Reported | (m) | -$21.94M | (m) | (m) | (m) | $13.08M* | $13.89M* | $92.01M | $7.89M | (m) | -$375.00K |
| 2024-03-31 | Reported | (m) | -$30.57M | (m) | (m) | (m) | $5.58M | -$25.91M | $90.77M | $7.62M | (m) | -$620.00K |
| 2023-09-30 | Reported | (m) | -$24.20M | (m) | (m) | (m) | $4.27M* | -$5.50M* | $89.64M | $5.29M | (m) | -$2.94M |
| 2023-06-30 | Reported | (m) | -$29.89M | (m) | (m) | (m) | $7.49M* | -$1.55M* | $87.03M | $7.50M | (m) | -$2.31M |
| 2023-03-31 | Reported | (m) | -$35.07M | (m) | (m) | (m) | $9.93M | -$12.69M | $82.41M | $7.39M | (m) | -$2.92M |
| 2022-09-30 | Reported | (m) | -$39.51M | (m) | (m) | (m) | $7.84M* | -$16.27M* | $79.89M | $7.31M | (m) | -$2.77M |
| 2022-06-30 | Reported | (m) | -$39.70M | (m) | (m) | (m) | $10.29M* | -$17.00M* | $81.13M | $8.63M | (m) | -$5.73M |
| 2022-03-31 | Reported | (m) | -$52.03M | (m) | (m) | (m) | $8.22M | -$29.04M | $78.94M | $7.71M | (m) | -$3.75M |
| 2021-09-30 | Reported | (m) | -$39.71M | (m) | (m) | (m) | $14.98M* | -$7.77M* | $74.10M | $7.41M | (m) | -$2.82M |
| 2021-06-30 | Reported | (m) | -$22.37M | (m) | (m) | (m) | $21.35M* | -$1.39M* | $68.73M | $3.50M | (m) | -$2.44M |
| 2021-03-31 | Reported | (m) | -$15.11M | (m) | (m) | (m) | $15.83M | $2.21M | $73.96M | $2.46M | (m) | $976.00K |
| 2020-09-30 | Reported | (m) | $4.67M | (m) | (m) | (m) | $7.86M* | $526.00K* | $71.38M | $1.96M | (m) | -$335.00K |
| 2020-06-30 | Reported | (m) | -$18.91M | (m) | (m) | (m) | $5.03M* | $1.88M* | $58.97M | $2.10M | (m) | -$11.13M |
| 2020-03-31 | Reported | (m) | -$5.29M | (m) | (m) | (m) | $4.71M | -$6.93M | $59.66M | $2.06M | (m) | $1.09M |
| 2019-09-30 | Reported | (m) | $3.66M | (m) | (m) | (m) | $7.32M* | $18.63M* | $53.84M | $2.61M | (m) | $1.35M |
| 2019-06-30 | Reported | (m) | $4.48M | (m) | (m) | (m) | $3.44M* | -$4.72M* | $52.75M | $2.59M | (m) | $175.00K |
| 2019-03-31 | Reported | (m) | $2.55M | (m) | (m) | (m) | $3.20M | $6.10M | $48.46M | $1.21M | (m) | -$2.02M |
| 2018-09-30 | Reported | (m) | $3.92M | (m) | (m) | (m) | $2.15M* | $8.38M* | $36.77M | $446.00K | (m) | $54.00K |
| 2018-06-30 | Reported | (m) | $794.00K | (m) | (m) | (m) | $4.28M* | $6.64M* | $37.22M | $1.07M | (m) | -$357.00K |
| 2018-03-31 | Reported | (m) | $2.50M | (m) | (m) | (m) | $4.67M | $14.31M | $36.12M | $956.00K | (m) | $438.00K |
| 2017-09-30 | Reported | (m) | -$2.06M | (m) | (m) | (m) | $2.30M* | $7.44M* | $34.24M | $1.27M | (m) | $802.00K |
| 2017-06-30 | Reported | (m) | $1.84M | (m) | (m) | (m) | $4.86M* | $6.53M* | (m) | $947.00K | (m) | -$53.00K |
| 2017-03-31 | Reported | (m) | -$580.00K | (m) | (m) | (m) | $3.01M | -$1.69M | (m) | $862.00K | (m) | -$779.00K |
| 2016-09-30 | Reported | (m) | $1.40M | (m) | (m) | (m) | $1.90M* | (m) | (m) | $967.00K | (m) | -$6.00K |
| 2016-06-30 | Reported | (m) | $2.19M | (m) | (m) | (m) | $2.42M* | (m) | (m) | $1.31M | (m) | $332.00K |
| 2016-03-31 | Reported | (m) | $1.92M | (m) | (m) | (m) | $1.00M | (m) | (m) | $1.45M | (m) | $174.00K |
| 2015-09-30 | Reported | (m) | $114.00K | (m) | (m) | (m) | $502.00K* | (m) | (m) | $871.00K | (m) | $1.00K* |
| 2015-06-30 | Reported | (m) | $28.00K | (m) | (m) | (m) | $338.00K* | (m) | (m) | $803.00K | (m) | $15.00K |
| 2015-03-31 | Reported | (m) | -$561.00K | (m) | (m) | (m) | $842.00K | (m) | (m) | $669.00K | (m) | $5.00K |
| 2014-09-30 | Reported | (m) | -$73.00K | (m) | (m) | (m) | (m) | (m) | (m) | $1.01M | (m) | (m) |
| 2014-09-30 | Reported | (m) | -$73.00K | (m) | (m) | (m) | $753.00K* | (m) | (m) | $1.01M | (m) | $0.00* |
| 2014-06-30 | Reported | (m) | $578.00K | (m) | (m) | (m) | $1.08M* | (m) | (m) | $633.00K | (m) | $51.00K |
| 2014-03-31 | Reported | (m) | $394.00K | (m) | (m) | (m) | $883.00K | (m) | (m) | $628.00K | (m) | $27.00K |
| 2013-09-30 | Reported | (m) | $1.16M | (m) | (m) | (m) | $878.00K* | $2.20M* | (m) | $340.00K | (m) | $29.00K |
| 2013-06-30 | Reported | (m) | $505.00K | (m) | (m) | (m) | $369.00K* | $1.86M* | (m) | $616.00K | (m) | $0.00* |
| 2013-03-31 | Reported | (m) | $305.00K | (m) | (m) | (m) | $239.00K | -$1.33M | (m) | $835.00K | (m) | $17.00K |
| 2012-09-30 | Reported | (m) | -$684.00K | (m) | (m) | (m) | $1.23M* | -$509.00K* | (m) | $808.00K | (m) | (m) |
| 2012-06-30 | Reported | (m) | $839.00K | (m) | (m) | (m) | $760.00K* | $1.08M* | (m) | $528.00K | (m) | (m) |
| 2012-03-31 | Reported | (m) | $861.00K | (m) | (m) | (m) | $277.00K | -$1.06M | (m) | $497.00K | (m) | (m) |
| 2011-09-30 | Reported | (m) | $42.00K | (m) | (m) | (m) | $213.00K* | -$116.00K* | (m) | $125.00K | (m) | (m) |
| 2011-06-30 | Reported | (m) | -$114.00K | (m) | (m) | (m) | $54.00K* | $490.00K* | (m) | $172.00K | (m) | (m) |
| 2011-03-31 | Reported | (m) | -$711.00K | (m) | (m) | (m) | $71.00K | -$1.54M | (m) | $119.00K | (m) | (m) |
| 2010-09-30 | Reported | (m) | -$1.01M | (m) | (m) | (m) | $313.00K* | -$925.00K* | (m) | (m) | (m) | (m) |
| 2010-06-30 | Reported | (m) | -$797.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$115.88M | (m) | (m) | (m) | $27.01M | $5.23M | $413.04M | $37.08M | (m) | -$2.24M |
| 2024-12-31 | Reported | (m) | -$92.11M | (m) | (m) | (m) | $41.06M | $7.02M | $370.47M | $31.16M | (m) | -$1.95M |
| 2023-12-31 | Reported | (m) | -$107.74M | (m) | (m) | (m) | $28.75M | -$1.95M | $347.04M | $27.31M | (m) | -$9.13M |
| 2022-12-31 | Reported | (m) | -$157.62M | (m) | (m) | (m) | $30.89M | -$65.99M | $321.83M | $30.33M | (m) | -$15.09M |
| 2021-12-31 | Reported | (m) | -$118.75M | (m) | (m) | (m) | $64.14M | -$26.72M | $297.27M | $21.87M | (m) | -$6.73M |
| 2020-12-31 | Reported | (m) | -$13.99M | (m) | (m) | (m) | $29.10M | $1.46M | $258.56M | $8.23M | (m) | -$18.23M |
| 2019-12-31 | Reported | (m) | $13.01M | (m) | (m) | (m) | $20.03M | $23.37M | $211.99M | $8.49M | (m) | -$4.36M |
| 2018-12-31 | Reported | (m) | $10.04M | (m) | (m) | (m) | $14.31M | $44.79M | $149.48M | $3.00M | (m) | $1.18M |
| 2017-12-31 | Reported | (m) | $2.90M | (m) | (m) | (m) | $13.69M | $18.04M | $138.29M | $3.64M | (m) | -$2.25M |
| 2016-12-31 | Reported | (m) | $2.15M | (m) | (m) | (m) | $7.54M | (m) | $133.70M | $4.65M | (m) | -$1.70M |
| 2015-12-31 | Reported | (m) | -$5.63M | (m) | (m) | (m) | $2.21M | (m) | (m) | $4.20M | (m) | -$1.95M |
| 2014-12-31 | Reported | (m) | $2.22M | (m) | (m) | (m) | $3.77M | (m) | (m) | $2.69M | (m) | $157.00K |
| 2013-12-31 | Reported | (m) | $3.17M | (m) | (m) | (m) | $2.01M | $2.23M | (m) | $2.44M | (m) | $152.00K |
| 2012-12-31 | Reported | (m) | $1.21M | (m) | (m) | (m) | $2.62M | -$492.00K | (m) | $2.28M | (m) | $0.00 |
| 2011-12-31 | Reported | (m) | -$409.00K | (m) | (m) | (m) | $897.00K | $69.00K | (m) | $543.00K | (m) | $0.00 |
| 2010-12-31 | Reported | (m) | -$2.96M | (m) | (m) | (m) | $916.00K | -$2.05M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |